2003•Journal of HepatologyRequires access

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation

Marı́a Buti, Antoni Mas, M. Prieto, Fernando Casafont, Antonio González, Manuel Miras, Jose-Ignacio Herrero, Rossendo Jardı́, Eva Cruz de Castro, César Garcı́a-Rey

Open publisher page 183 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 183 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Lamivudine, Medicine, Hepatitis B immune globulin, Hepatitis B virus, Liver transplantation, Nucleoside analogue, Gastroenterology, Hepatitis B

Back to paper search Browse research topics Original source

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation — Research Paper | ScholarLens